
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 175
Roberto Vendramin, Kevin Litchfield, Charles Swanton
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 175
Showing 1-25 of 175 citing articles:
Cell competition in development, homeostasis and cancer
Sanne M. van Neerven, Louis Vermeulen
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 3, pp. 221-236
Closed Access | Times Cited: 75
Sanne M. van Neerven, Louis Vermeulen
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 3, pp. 221-236
Closed Access | Times Cited: 75
Extracellular vesicles and particles impact the systemic landscape of cancer
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 74
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 74
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 49
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 49
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
Lise Mangiante, Nicolas Alcala, Alexandra Sexton‐Oates, et al.
Nature Genetics (2023) Vol. 55, Iss. 4, pp. 607-618
Open Access | Times Cited: 44
Lise Mangiante, Nicolas Alcala, Alexandra Sexton‐Oates, et al.
Nature Genetics (2023) Vol. 55, Iss. 4, pp. 607-618
Open Access | Times Cited: 44
Utilization of Functionalized Metal–Organic Framework Nanoparticle as Targeted Drug Delivery System for Cancer Therapy
Vy Anh Tran, Van Thuan Le, Van‐Dat Doan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 931-931
Open Access | Times Cited: 43
Vy Anh Tran, Van Thuan Le, Van‐Dat Doan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 931-931
Open Access | Times Cited: 43
Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
L. Francisco Lorenzo‐Martín, Tania Hübscher, Amber D. Bowler, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 450-457
Open Access | Times Cited: 36
L. Francisco Lorenzo‐Martín, Tania Hübscher, Amber D. Bowler, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 450-457
Open Access | Times Cited: 36
Extrachromosomal DNA in cancer
Xiaowei Yan, Paul S. Mischel, Howard Y. Chang
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 261-273
Closed Access | Times Cited: 27
Xiaowei Yan, Paul S. Mischel, Howard Y. Chang
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 261-273
Closed Access | Times Cited: 27
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Wade T. Iams, Matthew MacKay, Rotem Ben‐Shachar, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2351700-e2351700
Open Access | Times Cited: 26
Wade T. Iams, Matthew MacKay, Rotem Ben‐Shachar, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2351700-e2351700
Open Access | Times Cited: 26
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Lingpu Zhang, Jia‐Zhen Yang, Jia Huang, et al.
Chem (2024) Vol. 10, Iss. 5, pp. 1337-1356
Closed Access | Times Cited: 21
Lingpu Zhang, Jia‐Zhen Yang, Jia Huang, et al.
Chem (2024) Vol. 10, Iss. 5, pp. 1337-1356
Closed Access | Times Cited: 21
A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Li Kong, Komal Gupta, Andy Jialun Wu, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2269-2287.e16
Open Access | Times Cited: 17
Li Kong, Komal Gupta, Andy Jialun Wu, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2269-2287.e16
Open Access | Times Cited: 17
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 5
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 5
Modern biology of extrachromosomal DNA: A decade-long voyage of discovery
Qinglin Yang, Yulei Xie, Kailiang Qiao, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 11-22
Open Access | Times Cited: 3
Qinglin Yang, Yulei Xie, Kailiang Qiao, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 11-22
Open Access | Times Cited: 3
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Jack W. Scannell, Jim Bosley, John A. Hickman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 915-931
Open Access | Times Cited: 65
Jack W. Scannell, Jim Bosley, John A. Hickman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 915-931
Open Access | Times Cited: 65
Inflammation: A New Look at an Old Problem
Evgeni Gusev, Yulia A. Zhuravleva
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4596-4596
Open Access | Times Cited: 63
Evgeni Gusev, Yulia A. Zhuravleva
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4596-4596
Open Access | Times Cited: 63
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
Pauline Gilson, Jean‐Louis Merlin, Alexandre Harlé
Cancers (2022) Vol. 14, Iss. 6, pp. 1384-1384
Open Access | Times Cited: 59
Pauline Gilson, Jean‐Louis Merlin, Alexandre Harlé
Cancers (2022) Vol. 14, Iss. 6, pp. 1384-1384
Open Access | Times Cited: 59
Untangling the web of intratumour heterogeneity
Zheqi Li, Marco Seehawer, Kornélia Polyák
Nature Cell Biology (2022) Vol. 24, Iss. 8, pp. 1192-1201
Closed Access | Times Cited: 57
Zheqi Li, Marco Seehawer, Kornélia Polyák
Nature Cell Biology (2022) Vol. 24, Iss. 8, pp. 1192-1201
Closed Access | Times Cited: 57
Liquid biopsies to occult brain metastasis
Asad Ur Rehman, Parvez Κhan, Shailendra Kumar Maurya, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Asad Ur Rehman, Parvez Κhan, Shailendra Kumar Maurya, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
Lavinia Spain, Alexander Coulton, Irene Lobón, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1364-1385
Open Access | Times Cited: 37
Lavinia Spain, Alexander Coulton, Irene Lobón, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1364-1385
Open Access | Times Cited: 37
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells
Xiaoran Li, Yanping Zhong, Xudong Zhang, et al.
Oncogene (2023) Vol. 42, Iss. 9, pp. 665-678
Open Access | Times Cited: 33
Xiaoran Li, Yanping Zhong, Xudong Zhang, et al.
Oncogene (2023) Vol. 42, Iss. 9, pp. 665-678
Open Access | Times Cited: 33
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Talya L. Dayton, Nicolas Alcala, Laura Moonen, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2083-2099.e9
Open Access | Times Cited: 33
Talya L. Dayton, Nicolas Alcala, Laura Moonen, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2083-2099.e9
Open Access | Times Cited: 33
Cancer Evolution: A Multifaceted Affair
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 26
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 26
Clinical and translational relevance of intratumor heterogeneity
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 23
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 23
Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer
Soon Sang Park, Young‐Kyoung Lee, Yong Won Choi, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113912-113912
Open Access | Times Cited: 12
Soon Sang Park, Young‐Kyoung Lee, Yong Won Choi, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113912-113912
Open Access | Times Cited: 12
The evolutionary theory of cancer: challenges and potential solutions
Lucie Laplane, Carlo C. Maley
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 718-733
Closed Access | Times Cited: 12
Lucie Laplane, Carlo C. Maley
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 718-733
Closed Access | Times Cited: 12